Prostate cancer screening guidelines updated for the first time since 2010

The American Cancer Society (ACS) updated its prostate cancer screening guidelines on Nov. 12, 2026, for the first time since 2010. Previously, the ACS encouraged men to discuss screening benefits and risks with their healthcare providers. The updated guidelines recommend regular prostate-specific antigen (PSA) blood tests for men in certain age groups, with earlier and more frequent screening for those at higher risk.

What the new guidelines recommend 

Image
Older Black male looks at computer.
  • Men at average risk: PSA blood testing every two years from ages 50 to 69.
  • Men at high risk, including Black men and men with a strong family history of prostate cancer: Annual screening beginning at age 45 through age 69.
  • Men with one close relative diagnosed at age 65 or older: Screening every two years from ages 45 to 69.
  • Men ages 70 to 74: Discuss with a healthcare provider whether continued screening is appropriate.
  • Men age 75 and older: Routine screening is not recommended, although select healthy men may discuss continued testing with their provider.

Why the approach is changing

Prostate cancer is the second-leading cause of cancer death among men in the United States. Khanh Pham, MD, a urologist with Overlake Clinics Urology, says about two-thirds of prostate cancers grow slowly, while the remaining third can be aggressive.

Past concerns about overtreating slow-growing cancers led to more cautious screening recommendations. However, less screening may have contributed to more cancers being diagnosed at an advanced stage when treatment is more challenging.

“Screening recommendations have evolved over the years. It’s important for men to talk with their primary care providers about screening and when to begin based on their individual risk factors,” says Dr. Pham.

If further evaluation is needed, a urologist can help determine the best approach, whether that’s surgery, radiation therapy or active surveillance — monitoring a slow-growing cancer rather than treating it immediately.

“The goal is to ensure the right treatment for the right patient,” says Dr. Pham.

Categories:
SVG
Email icon

Sign Up for the Healthy Outlook eNewsletter